How ‘recession-proof’ is pharma, and what challenges has COVID-19 posed to this famously robust industry?

How can the pharmaceutical industry and, in particular, medical affairs teams, take pragmatic approaches to combat and curb antimicrobial resistance?

Celebrity endorsements can transform a mediocre pharma campaign into a pitch-perfect hit, but choosing the right spokesperson is crucial. We explore the practice of attaching famous faces to campaigns and how to ensure a representative strikes the right chord

Labelling is the vessel through which vital instructions and information about products are communicated to end-users, and in the pharmaceutical industry, medical affairs are entrusted with safeguarding these products from misuse, by balancing scientific accuracy with conciseness and coherence.

Innovative technology has changed the game in pharma, from AI-powered marketing campaigns to DNA sequencing tools. When this technology is combined with creative thinking, the potential for success is vast. It is critical for pharma to marry creativity with technology as they drive towards a patient-centric future

Francesca Wuttke, Chief Digital Officer, Almirall, shares her thoughts on how digital transformation, motivation and innovation can change patients’ lives for the better.

Rare diseases are complex conditions, but these patients are highly educated and determined, using platforms such as social media to make strides towards improving knowledge. It is vital that medical affairs executives consult these empowered, expert patients as they uncover unmet needs and think beyond the medication.

Meet the Chief Digital Officer: a person that ensures a pharmaceutical company evolves with the times through continued collaboration and culture shifts.